Black Diamond Therapeutics (BDTX) Institutional Ownership $2.43 -0.12 (-4.71%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Black Diamond Therapeutics (NASDAQ:BDTX)CurrentInstitutional OwnershipPercentage95.47%Number ofInstitutional Buyers(last 12 months)31TotalInstitutional Inflows(last 12 months)$30.51MNumber ofInstitutional Sellers(last 12 months)8TotalInstitutional Outflows(last 12 months)$6.68M Get BDTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Black Diamond Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BDTX Institutional Buying and Selling by Quarter Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Black Diamond Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/19/2024 Barclays PLC78,151$339K0.0%+201.9%0.138% 11/16/2024 Geode Capital Management LLC944,877$4.11M0.0%+12.2%1.670% 11/15/2024 Barclays PLC78,151$339K0.0%+201.9%0.138% 11/15/2024 Wellington Management Group LLP204,957$892K0.0%+12.8%0.362% 11/15/2024 State Street Corp809,196$3.52M0.0%+17.2%1.430% 11/15/2024 Point72 Asset Management L.P.697,125$3.03M0.0%N/A1.232% Get the Latest News and Ratings for BDTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Black Diamond Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/14/2024 Vestal Point Capital LP5,028,500$21.87M1.7%+139.5%8.887% 11/14/2024 Walleye Capital LLC11,195$49K0.0%N/A0.020% 11/14/2024 MetLife Investment Management LLC22,286$97K0.0%+129.1%0.039% 11/13/2024 FMR LLC179,068$779K0.0%N/A0.316% 11/12/2024 Charles Schwab Investment Management Inc.109,224$475K0.0%+6.9%0.193% 11/9/2024 Intech Investment Management LLC12,907$56K0.0%N/A0.023% 11/6/2024 Cornercap Investment Counsel Inc.22,583$98K0.0%-53.1%0.040% 10/21/2024 Foundations Investment Advisors LLC102,300$445K0.0%-9.9%0.182% 10/16/2024 Vontobel Holding Ltd.15,723$68K0.0%N/A0.028% 8/16/2024 Algert Global LLC28,501$133K0.0%N/A0.051% 8/15/2024 The Manufacturers Life Insurance Company60,189$280K0.0%N/A0.107% 8/15/2024 Affinity Asset Advisors LLC650,000$3.03M0.3%N/A1.155% 8/14/2024 Squarepoint Ops LLC25,351$118K0.0%-85.2%0.045% 8/14/2024 Marshall Wace LLP94,537$441K0.0%N/A0.168% 8/14/2024 Ally Bridge Group NY LLC835,000$3.89M2.3%N/A1.484% 8/12/2024 Marathon Trading Investment Management LLC19,116$89K0.0%-79.8%0.034% 8/9/2024 Renaissance Technologies LLC263,900$1.23M0.0%+24.1%0.469% 8/9/2024 Dimensional Fund Advisors LP200,044$932K0.0%+79.1%0.356% 8/3/2024 TD Asset Management Inc266,312$1.24M0.0%+275.9%0.473% 8/2/2024 Foundations Investment Advisors LLC113,550$529K0.0%+17.7%0.202% 8/1/2024 Rhumbline Advisers46,850$218K0.0%+10,334.3%0.083% 7/26/2024 Bank of New York Mellon Corp108,959$508K0.0%N/A0.194% 7/12/2024 SG Americas Securities LLC23,146$108K0.0%N/A0.041% 5/17/2024 Artal Group S.A.1,046,517$5.31M0.1%-48.9%1.860% 5/16/2024 Kennedy Capital Management LLC717,183$3.64M0.1%-3.2%1.275% 5/15/2024 Bellevue Group AG8,517,839$43.19M0.7%-0.2%15.142% 5/10/2024 Acadian Asset Management LLC170,510$864K0.0%+13.8%0.325% 5/10/2024 Vanguard Group Inc.1,905,300$9.66M0.0%-2.1%3.627% 5/7/2024Susquehanna Fundamental Investments LLC16,218$82K0.0%N/A0.031% 2/14/2024 Bellevue Group AG8,535,839$23.99M0.4%+4.9%16.533% 2/14/2024 Pale Fire Capital SE51,100$144K0.0%N/A0.099% 2/7/2024 Jump Financial LLC38,888$109K0.0%+245.0%0.075% 1/30/2024 Cornercap Investment Counsel Inc.82,784$233K0.0%N/A0.160% 12/6/2023 Citigroup Inc.61,348$176K0.0%N/A0.119% Trump said you could learn something from this man (Ad)Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know.11/14/2023 Newtyn Management LLC205,000$588K0.1%+2.5%0.397% 11/14/2023 Deerfield Management Company L.P. Series C930,447$2.67M0.1%-48.3%1.802% 11/13/2023CHI Advisors LLC720,000$2.07M0.6%-4.0%1.395% 11/13/2023 Algert Global LLC19,820$57K0.0%N/A0.038% 11/7/2023 Barclays PLC322,246$925K0.0%+159.1%0.625% 11/7/2023 Jump Financial LLC11,272$32K0.0%N/A0.022% 8/22/2023CHI Advisors LLC750,000$3.79M1.1%N/A2.054% 8/15/2023 RA Capital Management L.P.3,525,754$17.81M0.3%+36.1%9.657% 8/14/2023 Bellevue Group AG8,135,839$41.09M0.6%+50.8%22.282% 8/14/2023 Rock Springs Capital Management LP563,233$2.84M0.1%N/A1.543% 8/14/2023 Driehaus Capital Management LLC696,969$3.52M0.0%N/A1.909% 8/11/2023 VR Adviser LLC353,629$1.79M0.3%N/A0.969% 8/11/2023 Artal Group S.A.2,046,517$10.34M0.3%+24.3%5.605% 8/10/2023 Monashee Investment Management LLC170,000$858K0.2%N/A0.466% 8/8/2023 Candriam S.C.A.500,009$2.53M0.0%N/A1.370% 8/4/2023 Maven Securities LTD187,513$947K0.0%N/A0.514% 8/2/2023 Bank of Montreal Can15,000$76K0.0%N/A0.041% 7/12/2023 Herbst Group LLC13,635$69K0.0%N/A0.037% 7/12/2023 Beacon Capital Management LLC15,615$79K0.0%-56.2%0.043% 7/10/2023 AE Wealth Management LLC15,920$80K0.0%-55.7%0.044% 5/15/2023 EcoR1 Capital LLC1,191,094$2.25M0.1%+322.2%3.263% 5/8/2023 Federated Hermes Inc.13,185$25K0.0%-91.5%0.036% 2/14/2023 EcoR1 Capital LLC282,131$508K0.0%N/A0.776% 2/10/2023 K2 Principal Fund L.P.158,192$285K0.0%-84.7%0.435% 1/12/2023 Marquette Asset Management LLC34,400$62K0.0%N/A0.095% 11/14/2022Ergoteles LLC50,347$85K0.0%-54.2%0.138% 11/10/2022 Connor Clark & Lunn Investment Management Ltd.82,881$140K0.0%+572.2%0.228% 10/18/2022 Bailard Inc.21,281$36K0.0%-63.6%0.059% 10/5/2022 Beacon Capital Management LLC35,615$88K0.0%+48.4%0.098% 9/16/2022 Federated Hermes Inc.159,548$392K0.0%-84.6%0.439% 8/11/2022 Healthcare of Ontario Pension Plan Trust Fund73,100$180K0.0%-79.5%0.201% 8/5/2022 Connor Clark & Lunn Investment Management Ltd.12,330$30K0.0%N/A0.034% 8/3/2022 AE Wealth Management LLC36,385$90K0.0%+45.8%0.100% 7/27/2022 Bailard Inc.58,500$144K0.0%N/A0.161% 5/6/2022 Los Angeles Capital Management LLC88,887$246K0.0%+63.8%0.245% 4/18/2022 AE Wealth Management LLC24,963$69K0.0%+54.7%0.069% 2/14/2022 PDT Partners LLC74,036$395K0.0%-27.3%0.204% 2/14/2022 DAFNA Capital Management LLC206,100$1.10M0.3%N/A0.569% 2/11/2022 Bioimpact Capital LLC239,888$1.28M0.2%-3.5%0.662% 2/3/2022 Cambridge Investment Research Advisors Inc.11,031$59K0.0%N/A0.030% 2/2/2022 New York State Common Retirement Fund10,694$57K0.0%-36.0%0.030% 1/20/2022 AE Wealth Management LLC16,135$86K0.0%N/A0.045% 11/16/2021 Schonfeld Strategic Advisors LLC14,900$126K0.0%-47.7%0.041% 11/16/2021 Squarepoint Ops LLC20,092$170K0.0%N/A0.055% 11/16/2021 Two Sigma Advisers LP181,300$1.53M0.0%+115.3%0.500% 11/16/2021 Two Sigma Investments LP296,806$2.51M0.0%-28.3%0.819% 11/16/2021 Voloridge Investment Management LLC137,441$1.16M0.0%+8.9%0.379% 11/16/2021 BioImpact Capital LLC248,506$2.10M0.3%N/A0.686% 11/15/2021 Deerfield Management Company L.P. Series C760,128$6.43M0.1%-27.4%2.098% 11/15/2021 Dynamic Technology Lab Private Ltd10,307$87K0.0%N/A0.028% Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. 11/15/2021 GSA Capital Partners LLP69,299$586K0.1%-4.9%0.191% 11/15/2021 Martingale Asset Management L P36,920$313K0.0%+22.6%0.102% 11/12/2021Credit Suisse AG50,586$427K0.0%N/A0.140% 11/12/2021 Geode Capital Management LLC349,980$2.96M0.0%-2.7%0.966% 11/12/2021 Bank Julius Baer & Co. Ltd Zurich30,000$254K0.0%-50.4%0.083% 11/10/2021 Goldman Sachs Group Inc.126,106$1.07M0.0%-34.8%0.348% 11/10/2021 Citigroup Inc.48,898$414K0.0%-13.0%0.135% 11/10/2021 Healthcare of Ontario Pension Plan Trust Fund130,300$1.10M0.0%N/A0.360% 11/9/2021BlackRock Inc.2,190,630$18.53M0.0%+1.7%6.050% 11/8/2021 Los Angeles Capital Management LLC54,257$459K0.0%-8.6%0.150% (Data available from 1/1/2016 forward) BDTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BDTX shares? During the previous two years, 54 institutional investors and hedge funds held shares of Black Diamond Therapeutics. The most heavily invested institutionals were Bellevue Group AG ($43.19M), Vestal Point Capital LP ($21.87M), RA Capital Management L.P. ($17.81M), Vanguard Group Inc. ($9.66M), Artal Group S.A. ($5.31M), Geode Capital Management LLC ($4.11M), and Ally Bridge Group NY LLC ($3.89M).Learn more on BDTX's institutional investors. What percentage of Black Diamond Therapeutics stock is owned by institutional investors? 95.47% of Black Diamond Therapeutics stock is owned by institutional investors. Learn more on BDTX's institutional investor holdings. Which institutional investors have been buying Black Diamond Therapeutics stock? Of the 45 institutional investors that purchased Black Diamond Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Bellevue Group AG ($3.14M), Vestal Point Capital LP ($2.93M), EcoR1 Capital LLC ($1.19M), RA Capital Management L.P. ($935.85K), Ally Bridge Group NY LLC ($835K), CHI Advisors LLC ($750K), and Point72 Asset Management L.P. ($697.13K). How much institutional buying is happening at Black Diamond Therapeutics? Institutional investors have bought a total of 15,857,043 shares in the last 24 months. This purchase volume represents approximately $70.47M in transactions. Which Black Diamond Therapeutics major shareholders have been selling company stock? Of the 14 institutional investors that sold Black Diamond Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Artal Group S.A. ($1M), K2 Principal Fund L.P. ($873.32K), Deerfield Management Company L.P. Series C ($869.55K), Squarepoint Ops LLC ($146.03K), Federated Hermes Inc. ($142.03K), Marathon Trading Investment Management LLC ($75.28K), and Vanguard Group Inc. ($41.79K). How much institutional selling is happening at Black Diamond Therapeutics? Institutional investors have sold a total of 3,296,503 shares in the last 24 months. This volume of shares sold represents approximately $11.31M in transactions. Related Companies CGEN Institutional Ownership INBX Institutional Ownership ITOS Institutional Ownership CCCC Institutional Ownership CDXC Institutional Ownership IGMS Institutional Ownership ABVX Institutional Ownership HUMA Institutional Ownership ATXS Institutional Ownership ORGO Institutional Ownership This page (NASDAQ:BDTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Black Diamond Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Black Diamond Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
